S2 Therapeutics, Inc.
S2 Therapeutics is a specialty pharmaceutical organization, headquartered in Bristol, TN. S2 is the capital and commercialization partner for Cycloset and is holder of the exclusive global license for the manufacturing, marketing and distribution of Cycloset.
S2 seeks opportunities in the pharmaceutical industry through in-licensing arrangements, acquisitions of novel branded prescription pharmaceutical products, and investing in development compounds and companies.
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists.
In September of 2010 Santarus was granted exclusive rights to manufacture and commercialize Cycloset in the U.S.